Skip to main content
SpringerLink
Log in

Beta-adrenergic blocking drugs

  • Chapter
Drugs for Heart Disease

Abstract

The following account deals with the practical aspects of treatment with beta-adrenoceptor blocking drugs (popularly referred to as betablockers). Of the very many well-established, as well as tentative indications for treating patients with these drugs, some (angina, hypertension, secondary prevention of myocardial infarction) involve very large numbers of patients and long-term treatment. Hence, apart from clinical need, powerful commercial considerations have had an unduly important role in prompting the pharmaceutical industry into developing and marketing a myriad of alternative agents. The latter often differ from each other with respect to one or other of their minor ancillary properties, and frequently these form the basis on which individual agents are promoted. From the ensuing publications about different drugs and their respective differences from each other, an enormous quantity of medical literature has accumulated. Much of this was reviewed in the previous edition of this book [1]. More recent reviews, as well as detailed proceedings from symposia or workshops devoted to particular applications or particular drugs possessing specific ancillary properties, have appeared in profusion. A limited selection of these publications [2–5] can provide a useful update on most aspects of beta-blocking therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hamer, J. (1979) Beta-adrenergic blocking drugs. In Drugs for Heart Disease (Ed. J. Hamer ), Chapman and Hall, London, pp. 148–243.

    Google Scholar 

  2. Acta Med. Scand. (1981) Proceedings on a symposium on adrenoceptor blockade in hypertension. Acta Med. Scand., Suppl. 665, 1–147.

    Google Scholar 

  3. Richards, R. A., Robertson, J.I.S. and Prichard, B.N.C. (1982) Proceedings of the third symposium on labetolol - June 1981. Br. J. Clin. Pharmacol., Suppl 1, 13, 1S - 141S.

    Google Scholar 

  4. Aellig, W.H., Hedges, A., Turner, P. and Waite, R. (1982) Pindolol: the relevance of intrinsic sympathomimetic activity after 12 years of experience. Br. J. Clin. Pharmacol., 13, Suppl. 2, 143S - 450S.

    Google Scholar 

  5. Breckenridge, A. (1983) Which beta-blocker? Br. Med. J., 286, 1085–8.

    Article  CAS  Google Scholar 

  6. Zipper, J., Wheeler, R.G., Potts, D.M. and Rivera, M. (1983) Propranolol as a novel, effective spermicide: preliminary findings. Br. Med. J., 287, 1245–6.

    Article  CAS  Google Scholar 

  7. Patel, L.G., Warrington, S.J. and Pearson, R.M. (1983) Propranolol concentrations in plasma after insertion into the vagina. Br. Med. J., 287, 1237–320.

    Article  Google Scholar 

  8. Kumana, C.R. (1978) Selectivity of beta-adrenoceptor agonists and antagonists. In Recent Advances in Clinical Pharmacology 1 (eds P. Turner & D. Shand ), pp. 31–54.

    Google Scholar 

  9. Kumana, C.R. (1979) Selectivity of beta-blockers: Drug aspects. In Theories and Use of Beta-blockade in Hypertension and Angina. (ed. R.H. Roberts ), pp. 141–56, Symposia Specialists Inc., Miami, Fl. distributed by Year Book Medical Publishers, Chicago.

    Google Scholar 

  10. Carruthers, S.G. (1979) Cardioselectivity of beta-blockers: Theoretical aspects in Theories and Use of Beta-blockade in Hypertension and Angina. (ed. R.H. Roberts), pp. 125–40, Symposia Specialists Inc., Miami, Fl. distributed by Year Book Medical Publishers, Chicago.

    Google Scholar 

  11. McDevitt, D.G. (1978) Beta-adrenoceptor antagonists and respiratory function. Brit. J. Clin. Pharmacol., 5, 101–6.

    Article  Google Scholar 

  12. Perks, W.H., Chatterjee, R.S., Croxson, R.S. and Cruickshank, J.M. (1978) Beta-adrenoceptor antagonists and respiratory function. Br. J. Clin. Pharmacol., 6, 171.

    Article  PubMed  CAS  Google Scholar 

  13. Oh, V.M.S., Kaye, C.M., Warrington, S.J., Taylor, E.A. and Wadsworth, J. (1978) Beta-adrenoceptor antagonists and respiratory function. Br. J. Clin. Pharmacol., 6, 174–5.

    Article  Google Scholar 

  14. Ruffin, R.E., Freith, P.A., Anderton, R.C., Kumana, C.R., Newhouse, M.T. & Hargreave, F.E. (1979) Selectivity of beta-adrenoceptor antagonist drugs assessed by histamine bronchial challenge. Clin. Pharmacol. Ther., 25, 536–40.

    PubMed  CAS  Google Scholar 

  15. Taylor, S.H., Silke, B. and Lee, P.S. (1982) Intravenous beta-blockade in coronary heart disease. N. Engl. J. Med., 306, 631–5.

    Article  PubMed  CAS  Google Scholar 

  16. McDevitt, D.G. (1983) Clinical significance of cardioselectivity. Drugs, 25, Suppl. 2, 219–26.

    Google Scholar 

  17. McSorley, P.S. and Warren, D.J. (1978) Effects of propranolol and metoprolol on the peripheral circulation. Br. Med. J., 2, 1598–600.

    Article  PubMed  CAS  Google Scholar 

  18. Hiatt, W.R., Fradl, D.C., Zerbe, G.O. et al. (1984) Selective and non-selective beta-blockade of the peripheral circulation. Clin. Pharm. Ther., 35, 12–18.

    Article  CAS  Google Scholar 

  19. Louis, W.J. and McNeil, J.J. (1982) Can ISA compensate for bradycardia due to beta-adrenoceptor blockade?. Br. J. Clin. Pharmacol., 13, 315S - 320S.

    Article  Google Scholar 

  20. Kent, R.S. and Shand, D.G. (1981) Recent Advances in Cardiology, Vol. 8, Adrenergic Receptor Regulation, (ed. J. Hamer), Churchill Livingstone, Edinburgh, ch. 16.

    Google Scholar 

  21. Miller, R.R., Olsen, H.G., Amsterdam, E.A. and Mason, D.T. (1975) Propranolol withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of anti-anginal treatment. N. Engl. J. Med., 293, 416–8.

    Article  PubMed  CAS  Google Scholar 

  22. Nattel, S., Rangno, R.E. and Van Loon, G. (1979) Mechanism of propranolol withdrawal phenomena. Circulation, 59, 1158–64.

    Article  PubMed  CAS  Google Scholar 

  23. Prichard, B.N.C., Tomlinson, B., Walden, R.J. and Bhattacharjee, P. (1983) The beta-adrenergic blockade withdrawal phenomenon. J. Cardiovasc. Pharmacol., 5, Suppl. 1, S56–62.

    Google Scholar 

  24. Lindenfeld, J., Crawford, M.H., O’Rourke, A. et al. (1980) Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. Circulation, 62, 704–11.

    Article  PubMed  CAS  Google Scholar 

  25. van Brummelen, P. (1983) The relevance of intrinsic sympathomimetic activity for beta-blocker induced changes in plasma lipids. J. Cardiovasc. Pharmacol., 5, Suppl. 1, S51–5.

    Google Scholar 

  26. Editorial (1981) Management of orthostatic hypotension, Lancet, ii, 963–4.

    Google Scholar 

  27. Man In ‘T’ Veld, A.J., Boomsa, F. and Shalekamp, M.A.D.H. (1983) Regulation of alpha and beta-adrenoceptor responsiveness. Studies in patients with chronic autonomic failure. Br. J. Clin. Pharmacol.,15 Suppl, 507S–519S.

    Google Scholar 

  28. Lohmoller, G. and Stocker, K. (1982) Can ISA compensate for bradycardia due to beta-adrenoceptor blockade? Br. J. Clin. Pharmacol., 13, 315S - 320S.

    Article  PubMed  CAS  Google Scholar 

  29. Hombach, V., Braun, V., Hopp, H.W., Gil-Sanchez, D., et al. (1982) Electrophysiological effects of cardioselective and non-cardioselective betaadrenoceptor blockers with and without ISA at rest and during exercise. Br. J. Clin. Pharmacol., 13, 285S - 93S.

    Article  PubMed  CAS  Google Scholar 

  30. Hansson, L., Svensson, A., Gudbronolsson, T., et al. (1983) Treatment of hypertension with beta-blockers with and without intrinsic sympathomimetic activity. J. Cardiovasc.Pharmacol., 55, Suppl. 1, 526–9.

    Google Scholar 

  31. Shand, D.G. (1983) State of the art: comparative pharmacology of the betaadrenoceptor blocking drugs. Drugs, 25, Suppl. 2, 92–9.

    Google Scholar 

  32. Schafer-Korting, M., Bach, N., Knauf, H. and Mutschler, E. (1984) Pharmacokinetics of nadolol in healthy subjects. Eur. J. Clin. Pharmacol., 26, 125–7.

    Article  PubMed  CAS  Google Scholar 

  33. Kirch, W., Spahn, H., Kohler, H. and Mutschler, E. (1983) Influence of beta-receptor antagonists on pharmacokinetics of cimetidine. Drugs, 25, Suppl. 2, 127–30.

    Google Scholar 

  34. Wood, A.J.J. (1983) Beta-blocker withdrawal. Drugs, 25, Suppl. 2, 318–21.

    Google Scholar 

  35. Warren, D.J., Waller, D.G. and McAinish, J. (1983) Beta-blockers and renal function. Drugs, 25, Suppl. 2, 108–12.

    Google Scholar 

  36. Lebrec, D., Flouvat, B., Decourt, S. and Dupont, C. (1983) Atenolol and liver function. Drugs, 25, Suppl. 2, 147.

    Google Scholar 

  37. Balant, L.P. and Fabre, J. (1978) Low dose oral propranolol. Lancet, ii, 425.

    Google Scholar 

  38. Turner, P. (1983) Beta-adrenoceptor blocking drugs and the central nervous systems. Recent Advances on Clinical Pharmacology, Vol. 3, Churchill Livingstone, Edinburgh, ch. 11, pp. 223–34.

    Google Scholar 

  39. Garvey, A.J., McDevitt, D.G. and Solem, S.A.M. (1984) Comparative study of the psychomotor effects of atenolol, nadolol, propranolol and diazepam in man. Brit. J. Clin. Pharm., 17. 216 P.

    Google Scholar 

  40. Betts, T. A. and Alford, C. (1983) Beta-blocking drugs and sleep; a controlled trial. Drugs, 25, Suppl. 2, 268–72.

    Google Scholar 

  41. Westerlund, A. (1983) A comparison of the central nervous system side-effects caused by lipophilic and hydrophilic beta-blockers. Br. J. Clin. Pharmacol., 280–1.

    Google Scholar 

  42. Offerhaus, L. and Van Zweitan, P.A. (1974) Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol and their enantiomers. Cardiovascular Res., 8, 488.

    Article  CAS  Google Scholar 

  43. Danesh, B.J.Z., Brunton, J. and Sumner, D.J. (1984) Comparison between short-term renal hemodynamic effects of propranolol and nadolol in essential hypertension: a crossover study. Clinical Science, 67, 243–8.

    PubMed  CAS  Google Scholar 

  44. Mueller, J., Byrne, M.J. Van Schalkwyk, J. and Opie, L.H. (1983) Renal impairment in hypertension not improved by nadolol when compared with atenolol. Drugs, 25, Suppl. 2, 146.

    Article  Google Scholar 

  45. Gross, F. (1982) The place of alpha-adrenoceptor and beta-adrenoceptor blockade in the treatment of hypertension. Br. J. Clin, Pharmacol., 13, Suppl. 1, 5S - 11S.

    Google Scholar 

  46. Breckenridge, A., Orme, M., Serlin, M.J. and Maclver, M. (1982) Labetolol in essential hypertension. Br. J. Clin. Pharmacol., 13, Suppl. 1, 37S - 9S.

    Article  Google Scholar 

  47. Prichard, B.N.C. and Richards, D.A. (1982) Comparison of labetolol with other anti-hypertensive drugs. ‘Third Drug’ trial - comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta-blocker plus thiazide diuretic. Br. J. Clin. Pharmacol., 13, Suppl. 1, 41S - 7S.

    Article  Google Scholar 

  48. McAreavey, D., Ramsey, L.E., Latham, L., McLaren, A.D., Lorimer, A.R., Reid, J.L., Robertson, J.I.S., Robertson M.P. and Weir, R.J. (1984) ‘Third drug’ trial: comparative study of anti-hypotensive agents added to treatment when blood pressure remains uncontrolled by a beta-blocker plus thiazide diuretic. Br. Med. J., 288, 106–11.

    Google Scholar 

  49. Waal-Manning, H.J. and Simpson, F.O. (1982) Review of long-term treatment with labetolol. Br. J. Clin. Pharmacol., 13, Suppl. 1, 65S - 73S.

    Article  Google Scholar 

  50. Hughes, G.V.R. (1982) Hypotensive agents, beta-blockers and drug-induced lupus. Br. Med. J., 284, 1358–9.

    Article  CAS  Google Scholar 

  51. Cumming, A.M.M., Brown, J.J., Lever, A.F. and Robertson, J.I.S. (1982) Intravenous labetolol in the treatment of severe hypertension. Br. J. Clin. Pharmacol., 13, Suppl. 1, 93S - 6S.

    Article  Google Scholar 

  52. Davies, A.B., Balasubramanian, V., Gould, B. and Raftery, E.B. (1982) Rapid reduction of blood pressure with acute oral labetolol. Br. J. Clin. Pharmacol., 13, 705–10.

    Article  PubMed  CAS  Google Scholar 

  53. Agabitit-Rosei, E., Alicandri, C.L., Beschi, M., Castellano, M., Fariello, R., Montini, E., Muiesa, M.L. Romanelli, G. and Muiesan, G. (1982) The acute and chronic effect of labetolol and the relationship with pretreatment plasma noradrenaline levels. Br. J. Clin. Pharmacol., 13, Suppl. 1, 87S - 92S.

    Article  Google Scholar 

  54. Freis, E.D. (1982) The veterans and sequelae. Br. J. Clin. Pharmacol., 13, 67–72.

    PubMed  CAS  Google Scholar 

  55. Prichard, B.N.C. (1982) Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension. Br. J. Clin. Pharmacol., 13, 51–60.

    PubMed  CAS  Google Scholar 

  56. Greenberg, G., Brennan, P.J. and Miall, W.E. (1984) Effects of diuretic and beta-blocker therapy in the Medical Research Council trial. Am. J. Med., 76, 45–51.

    Article  PubMed  CAS  Google Scholar 

  57. Beevers, D.G., Johnston, H., Larkin, H. and Davies, P. (1983) Clinical evidence that beta-adrenoceptor blockers prevent more cardiovascular complications than other antihypertensive drugs. Drugs, 25, Suppl. 2, 326–30.

    Google Scholar 

  58. Multiple Risk Factor Intervention Trial Research Group (1982) Multiple risk factor intervention trial: Risk factor changes and mortality results. J. Am. Med. Assoc., 248, 1465–77.

    Article  Google Scholar 

  59. Goldenberg, M., Pines, M.L., Baldwin, E. de B., Greene, D.C. and Roh, L.E. (1948) The hemodynamic response of man to norepinephrine and epinephrine and its relation to the problem of hypertension. Am. J. Med., 5, 792–806.

    Article  PubMed  CAS  Google Scholar 

  60. Barcroft, H. and Starr, I. (1951) Comparison of the actions of adrenaline and noradrenaline on the cardiac output in man. Clin. Sci., 10, 295–301.

    PubMed  CAS  Google Scholar 

  61. Prichard, B.N.C. and Ross, F.T. (1966) Use of propranolol in conjunction with alpha-receptor blocking drugs in phaeochromocytoma. Am. J. Cardiol., 18, 394.

    Article  PubMed  CAS  Google Scholar 

  62. Van Herwaarden, C.L.A., Binkhorst, R.A., Fennis, J.F.M. and Van’t Laar, A. (1977) Effects of adrenaline during treatment with propranolol. Br. Med. J., 1, 1029.

    Article  PubMed  Google Scholar 

  63. Van Herwaarden, C.L.A., Binkhorst, R.A. and Fennis, J.F.M. (1979) Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients. Br. Heart J., 41, 99.

    Article  PubMed  Google Scholar 

  64. Morrison, S.C., Kumana, C.R., Rudnick, K.V., Haynes, B. and Jones, N.L. (1982) Selective and non-selective beta-adrenoceptor blockade in hypertension: responses to changes in posture, cold and exercise. Circulation, 65, 1171–7.

    Article  PubMed  CAS  Google Scholar 

  65. Kumana, C.R. (1986) Are blood pressure surges associated with sympathetic stimulation aggravated by beta-adrenoceptor antagonist treatment. Post. Grad. Med. J., 62, 731–5.

    Article  CAS  Google Scholar 

  66. Miall, W.E. and Chinn, S. (1974) Framingham study: Screening for hypertension: some epidemiological observations. Br. Med. J., 3, 595.

    Article  PubMed  CAS  Google Scholar 

  67. Norris, R.M., Barnaby, P.F., Brown, M.M., Green, G.G., Clark, E.D. Logan, D.L., and Sharp, D.N. (1984) Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet, ii, 883–6.

    Google Scholar 

  68. Pratt, C.M. and Roberts, E. (1983) Chronic beta-blockade therapy in patients after myocardial infarction. Am. J. Cardiol., 52, 661–4.

    Article  PubMed  CAS  Google Scholar 

  69. Factor, S.M., Okun, E.M., Minesi, T. and Kirk, E.S. (1982) The microcirculation of the human heart: end-capillary loops with discrete perfusion fields. Circulation, 66, 1241–8.

    Article  PubMed  CAS  Google Scholar 

  70. Norris, R.M. (1985) Beta-adrenoceptor blockers–an update on their role in actue myocardial infarction. Drugs, 29, 97–104.

    Article  PubMed  CAS  Google Scholar 

  71. Martindale (1982) Propranolol and other beta-adrenoceptor blocking agents. In The Extrapharmacopoeia, 28th edn, Pharmaceutical Press, London, pp. 132–452.

    Google Scholar 

  72. Amery, A., DePlaen, J.F., Lignen, P., McAinish, J. and Reybrouck, T. (1977) Relationship between blood level of atenolol and pharmacologic effect. Clin. Pharmacol. Ther., 21, 691–9.

    PubMed  CAS  Google Scholar 

  73. Hitzenberger, G. (1979) Plasma concentration and antihypertensive effect of beta-blockers. Cardiology, 645, Suppl. 1, 14–19.

    Google Scholar 

  74. Scott, A.K., Rigby, J.W., Webster, J., Haeksworth, G.M., Petrie, J.C. and Lovell, H.G. (1982) Atenolol and metoprolol once daily in hypertension. Br. Med. J., 284, 1514–16.

    Article  CAS  Google Scholar 

  75. Mann, S., Millar-Crad, M.W., Gould, B.A., Melville, D.I. and Raftery, E.B. (1982) Coital blood pressure in hypertensives: Cephalgia, syncope and the effects of beta-blockade. Br. Heart J., 47, 84–9.

    Article  PubMed  CAS  Google Scholar 

  76. Raftery, E.B. (1983) The effects of beta-blocker therapy on diurnal variation of blood pressure. Eur. Heart. J., 4, Suppl. D., 61–4.

    Google Scholar 

  77. Serlin, M.J., Orme, M.L.E., Baber, N.S. and Sibeon, R.G. (1980) Propranolol in the control of blood pressure: A dose response study. Clin. Pharmacol. Ther., 27, 586–92.

    Article  PubMed  CAS  Google Scholar 

  78. Thadani, U. and Parker, J.O. (1979) Propranolol in the treatment of angina pectoris: Comparison of duration of action in acute and sustained therapy. Circulation, 59, 571–9.

    Article  PubMed  CAS  Google Scholar 

  79. Shand, D.G. (1974) Pharmacokinetic properties of the beta-adrenergic blocking drugs. Drugs, 7, 39–47.

    Article  PubMed  CAS  Google Scholar 

  80. Walle, T., Conradi, E.L., Walle, U.K., Fagan, T.L. and Gaffney, T.E. (1978) The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin. Pharm. and Thero., 24, 668–77.

    CAS  Google Scholar 

  81. Woosley, R.L., Kornhauser, D. Smith, R., Roebe, S., Higgins, B., Nies, A.S., Shand, D.G. and Oates, T.A. (1979) Suppression of chronic ventricular arrhythmias with propranolol. Circulation, 60, 819–27.

    Article  PubMed  CAS  Google Scholar 

  82. Kendall, M.J. and Beeley, L. (1983) Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactions. Pharmacol. Ther., 21, 351–69.

    Article  PubMed  CAS  Google Scholar 

  83. Murakami, K., Kosania, T., Hyashi, R., Tsushima, M. et al. (1982) Myxoedema coma induced by beta-adrenoceptor blocking agent. Br. Med. J., 285, 543–4.

    Article  CAS  Google Scholar 

  84. Wright, P. (1979) The practolol adverse reaction and the significance of reactions to other beta-blockers. In Theories and Use of Beta-blockade in Hypertension and Angina (ed. R.H. Roberts ), pp. 115–23. Symposia Specialists Inc., Miami. Fl., distributed by Year Book Medical Publishers, Chicago.

    Google Scholar 

  85. Fololt, R., Lieollious, H. and Aursnes, J. (1985) Beta-blockers and loss of hearing. Br. Med. J., 289, 1490–2.

    Google Scholar 

  86. Lennard, M.S. (1985) Oxidation phenotype and the metabolism and action of beta-blockers. Klin. Wochenschr., 63, 285–92.

    Article  PubMed  CAS  Google Scholar 

  87. Woods, H.F., Lennard, M.S. and Tucker, G.T. (1985) Genetic polymorphism of drug oxidation - ethnic differences. Proc. SE Asian/Western Pacific Regional Meeting of Pharmacologists (in press).

    Google Scholar 

  88. Lewis, P. (1983) Clinical Pharmacology and Obstetrics. John Wright, Bristol, London and Boston, Ch. 9, pp. 100–2.

    Google Scholar 

  89. Vanhalweyk, J.L.J., Serruys, P.W. and Hugenholtz, P.G. (1983) Anti-anginal electrophysiologic and hemodynamic effects of combined beta-blocker/ calcium antagonist therapy. Eur. Heart J., 4, Suppl. D, 117–28.

    Google Scholar 

  90. Kendall, M.J. (1981) Are selective beta-adrenoceptor blocking drugs an advantage? J. Roy. Coll. Phys. (Lond.), 15, 33–40.

    CAS  Google Scholar 

  91. Stornello, M., Di Rao, G., Iachello, B., Pantano, S., Isani, R., and Scapellato, L. (1983) Effects of salbutamol, indomethacin and atenolol on insulin secretion. Drugs, 25, Suppl. 2, 255–6.

    Google Scholar 

  92. Ryan, J.R., Lacorte, W., Jan, A. and McMahon, F.G. (1983) Response of diabetics treated with atenolol and propranolol to insulin-induced hypoglycemia. Drugs, 25, Suppl. 2, 256–7.

    Google Scholar 

  93. Holm, G., Herlitz, J. and Smith, U. (1981) Severe hypoglycemia during physical exercise and treatment with beta-blockers. Br. Med. J., 282, 1360.

    Article  CAS  Google Scholar 

  94. Rutsky, E.A., McDaniel, H.G., Tharpe, D.L. et al. (1978) Spontaneous hypoglycemia in chronic renal failure. Arch. Int. Med., 138, 1364–8.

    Article  CAS  Google Scholar 

  95. Pun, K.K., Yeung, C.K., Ho, P.W.M., Lin, H.J., Chan, M.K. and Yeung, R.T.T. (1984) Effects of propranolol and haemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge. Clin. Nephrol., 21, 235–40.

    PubMed  CAS  Google Scholar 

  96. Pun, K.K., Yeung, C.K. and Yeung, R.T.T. (1985) Effects of propranolol and metoprolol on glucose, cyclic AMP and insulin responses during pharmacological hyperglucosuraemia in haemodialysis patients. Nephron, 39, 175–8.

    Article  PubMed  CAS  Google Scholar 

  97. Feeley, J. and Peden, N. (1984) Use of beta-adrenoceptor blocking drugs in hyperthyroidism, Drugs. 27, 425–6.

    Article  Google Scholar 

  98. Tyrer, P.J. (1980) Use of beta-blocking drugs in psychiatry and neurology. Drugs, 22, 300–8.

    Article  Google Scholar 

Download references

Authors
  1. Cyrus R. Kumana
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Formerly Consultant Cardiologist, now retired, Department of Clinical Pharmacology, St Bartholomew’s Hospital, EC1A 7BE, London, UK

    John Hamer MD. Ph.D F.R.C.P.

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Kumana, C.R. (1987). Beta-adrenergic blocking drugs. In: Hamer, J. (eds) Drugs for Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3294-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-3294-5_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-26540-2

  • Online ISBN: 978-1-4899-3294-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation